Kestra Advisory Services, LLC Leap Therapeutics, Inc. Transaction History

Kestra Advisory Services, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 01, 2022	BUY	$0.92 - $9.3 $10,580 - $106,950	11,500 New	11,500 $10 Million
Q1 2021 May 10, 2021	SELL	$1.82 - $3.01 $20,930 - $34,615	-11,500 Closed	0 $0
Q4 2020 Jan 20, 2021	BUY	$1.49 - $2.37 $17,135 - $27,255	11,500 New	11,500 $25 Million

265K

Ticker LPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,021,400
Market Cap $344M
Description
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Kestra Advisory Services, LLC with notifications on news.